James Comtois Biotech Rebound Boosts Doris Duke’s Mission-Aligned Portfolio Life sciences is just one part of the foundation’s impact investment strategy, but the sector’s resurgence helped contribute to strong gains in 2025. James Comtois February 25, 2026